Ex-vivo Expansion of Autologous Cell Therapy Products

12 Nov 2012

Learn how the CellBase CT from TAP Biosystems, which has been specifically developed to enable the automated ex-vivo expansion of autologous cell therapies, enables multiple individual patient products to be processed in parallel without contamination or cross-contamination occurring.

Links

Tags